Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer

by Colin R. Lindsay, Pavlina Spiliopoulou, Ashita Waterston
Published 2015-03-01

Modafinil in the rehabilitation of a patient with post-surgical posterior fossa syndrome: a lesson to be learned?

by Emanuela Molinari, Maria Oto, Ashita Waterston, Natasha Fullerton
Published 2019-08-01

Testicular cancer: improving outcomes with national quality performance indicators

by Ashita Waterston, Jeff White, Mark A Baxter, Graham MacDonald, Jahangeer Malik, Alistair Law, Åsa Dahle-Smith, Walter Mmeka, Roland Donat, Cj Shukla, John Connor, Colin Houston
Published 2020-03-01

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer

by Alan C. Cameron, MBChB, PhD, Kelly McMahon, BSc, Mark Hall, MBChB, Karla B. Neves, PhD, Francisco J. Rios, PhD, Augusto C. Montezano, PhD, Paul Welsh, PhD, Ashita Waterston, MBChB, PhD, Jeff White, MBChB, DM, Patrick B. Mark, MBChB, PhD, Rhian M. Touyz, MBBCh, PhD, Ninian N. Lang, MBChB, PhD
Published 2020-09-01

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT

by Timothy Iveson, Kathleen A Boyd, Rachel S Kerr, Jose Robles-Zurita, Mark P Saunders, Andrew H Briggs, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David Propper, John Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet Wasan, James Paul
Published 2019-12-01